NEW YORK (GenomeWeb News) - Tm Bioscience said today that it has negotiated a $4 million operating credit facility with Laurus Master Fund.
 
Tm said it plans to use the funds for general operating purposes while its board of directors completes its previously disclosed review of the company’s strategic alternatives, which include the sale or merger of the company.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.